DDX41 and Its Unique Contribution to Myeloid Leukemogenesis
July 19, 2024
PRESS RELEASE: On July 2, 2024, a new editorial was published in Oncotarget, entitled, “DDX41 and its unique contribution to myeloid leukemogenesis.” continue reading »